0001974158-24-000029.txt : 20240411
0001974158-24-000029.hdr.sgml : 20240411
20240411170136
ACCESSION NUMBER: 0001974158-24-000029
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240411
DATE AS OF CHANGE: 20240411
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 24839175
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kintz Samuel
CENTRAL INDEX KEY: 0001967168
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: ENLIVEN THERAPEUTICS INC
STREET 2: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
144
1
primary_doc.xml
144
0001967168
XXXXXXXX
LIVE
0001672619
Enliven Therapeutics, Inc.
001-39247
6200 LOOKOUT ROAD
BOULDER
CO
80301
720-647-8519
Kintz Samuel
Officer
Common
Jefferies LLC
520 Madison Ave, 4th Fl
New York
NY
10022
59709
1183432.38
41000000
04/11/2024
NASDAQ
Common
06/16/2020
Stock Options Grant
Enliven Therapeutics Inc
N
59709
06/16/2020
06/16/2020
N
Samuel Kintz
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
01/25/2024
12000
188229.48
Samuel Kintz
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
02/26/2024
12000
202653.84
Samuel Kintz
6200 Lookout Rd 1st FL
Boulder
CO
80301
Enliven Therapeutics
03/25/2024
12000
210661.32
All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 06/26/2023, and all representations regarding material non-public information were made as of the adoption of the plan.
04/11/2024
06/26/2023
Samuel Kintz